Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBS-301 in Idiopathic Hypersomnia
NCT07500090Phase 3Recruiting
- Sponsor
- Harmony Biosciences
- Start
- Mar 2026
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of pitolisant in idiopathic hypersomnia (IH), sponsored by Harmony Biosciences. Started Mar 2026; status: recruiting.
02
Drugs
pitolisant
03
Conditions
idiopathic hypersomnia (IH)
Beyond the preview
Go deeper on NCT07500090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07500090.